Want to join the conversation?
$WBA expects FY16 adjusted net diluted EPS to be in the range of $4.30-4.55, an increase of $0.05 per share at the low end of the guidance number. The guidance does not assume any material addition to earnings from the company's proposed acquisition of Rite Aid, which is expected to close in the second half of calendar 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.